Guardant Health 非 GAAP 每股收益为 - 0.39 美元，超出 0.10 美元，收入为 2.652 亿美元，超出 2,951 万美元

* Guardant Health 新闻稿 [https://seekingalpha.com/pr/20285132-guardant-health-reports-third-quarter-2025-financial-results-and-increases-2025-revenue] (GH [https://seekingalpha.com/symbol/GH])：第三季度非 GAAP 每股收益 - 0.39 美元，比 0.10 美元高出 0.10 美元。 2.652 亿美元（同比增长 38.5%）超过 2951 万美元。有关 GUARDANT HEALTH 的更多信息 * Guardant Health：在第三季度估值和执行风险结果公布之前维持评级[https://seekingalpha.com/article/4829725-guardant-health-hold- rating-ahead-of-q3-on-valuation-and-execution-risk] * Guardant Health, Inc. (GH) 2025 年投资者日演讲 [https://seekingalpha.com/article/4825659-guardant-health-inc-gh-2025-investor-day-presentation] * Guardant Health, Inc. (GH) 2025 年投资者日电话会议（文字记录）[https://seekingalpha.com/article/4825583-guardant-health-inc-gh-2025-investor-day-call-transcript] * Guardant Health 2025 年第三季度收益预览[https://seekingalpha.com/news/4509418-guardant-health-q3-2025-earnings-preview] * Guardant Health 与 Zephyr AI 合作寻找用于癌症靶向治疗的生物标志物 [https://seekingalpha.com/news/4508711-guardant-health-zephyr-ai-partner-find-biomarkers-targeted-cancer-treatments]